MARKET

CGEN

CGEN

Compugen
NASDAQ
2.575
+0.135
+5.53%
Opening 13:56 08/20 EDT
OPEN
2.540
PREV CLOSE
2.440
HIGH
2.619
LOW
2.470
VOLUME
543.23K
TURNOVER
--
52 WEEK HIGH
3.235
52 WEEK LOW
1.295
MARKET CAP
243.92M
P/E (TTM)
7.09
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CGEN last week (0810-0814)?
Weekly Report · 3d ago
Weekly Report: what happened at CGEN last week (0803-0807)?
Weekly Report · 08/10 10:24
Compugen: Better Runway Ahead Of MAIA
Seeking Alpha · 08/07 03:59
Compugen Earnings Call Highlights Long-Term Biotech Upside
TipRanks · 08/05 00:47
H.C. Wainwright Keeps Their Buy Rating on Compugen (CGEN)
TipRanks · 08/04 08:57
Compugen Sets September 10, 2026 Annual Meeting, Details Board, Pay and Auditor Votes
TipRanks · 08/03 12:29
Compugen (CGEN) Reports Q2 Loss, Misses Revenue Estimates
NASDAQ · 08/03 12:05
Compugen Posts Q2 2026 Results as Key Cancer Immunotherapy Trials Advance
TipRanks · 08/03 11:27
More
About CGEN
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.

Webull offers Compugen Ltd (USA) stock information, including NASDAQ: CGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CGEN stock methods without spending real money on the virtual paper trading platform.